These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24842387)

  • 1. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
    Lee JS; Rosengart MR; Kondragunta V; Zhang Y; McMurray J; Branch RA; Choi AM; Sciurba FC
    Respir Res; 2007 Sep; 8(1):64. PubMed ID: 17868461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
    Zhang L; Cheng Z; Liu W; Wu K
    COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of dendritic cell co-stimulation in COPD.
    Stoll P; Ulrich M; Bratke K; Garbe K; Virchow JC; Lommatzsch M
    Respir Res; 2015 Feb; 16(1):19. PubMed ID: 25775429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease.
    Chan KH; Yeung SC; Yao TJ; Ip MS; Cheung AH; Chan-Yeung MM; Mak JC;
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1193-200. PubMed ID: 20819268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
    Di Stefano A; Coccini T; Roda E; Signorini C; Balbi B; Brunetti G; Ceriana P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1691-1700. PubMed ID: 29872287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema.
    Omori H; Tsuji M; Sata K; Iyonaga C; Narimatsu A; Mihara S; Marubayashi T; Tomiguchi S; Nomori H; Kohrogi H; Katoh T
    Respirology; 2009 May; 14(4):551-8. PubMed ID: 19386068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.
    Bon JM; Leader JK; Weissfeld JL; Coxson HO; Zheng B; Branch RA; Kondragunta V; Lee JS; Zhang Y; Choi AM; Lokshin AE; Kaminski N; Gur D; Sciurba FC
    PLoS One; 2009 Aug; 4(8):e6865. PubMed ID: 19718453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Schmidt M; de Koning HJ; van der Aalst C; Oudkerk M; Vliegenthart R; Groen HJ; van Ginneken B; van Rikxoort EM; Zanen P
    Eur Respir J; 2015 Mar; 45(3):644-51. PubMed ID: 25614166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD.
    Gietema HA; Edwards LD; Coxson HO; Bakke PS;
    Respir Med; 2013 Aug; 107(8):1201-9. PubMed ID: 23711580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease.
    Sugiyama Y; Asai K; Yamada K; Kureya Y; Ijiri N; Watanabe T; Kanazawa H; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():765-772. PubMed ID: 28424548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1.
    Coxson HO; Leipsic J; Parraga G; Sin DD
    Am J Respir Crit Care Med; 2014 Jul; 190(2):135-44. PubMed ID: 24873985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of blood cytokines and chemokines in assessing COPD.
    Bradford E; Jacobson S; Varasteh J; Comellas AP; Woodruff P; O'Neal W; DeMeo DL; Li X; Kim V; Cho M; Castaldi PJ; Hersh C; Silverman EK; Crapo JD; Kechris K; Bowler RP
    Respir Res; 2017 Oct; 18(1):180. PubMed ID: 29065892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Bhatt SP; Nath HP; Kim YI; Ramachandran R; Watts JR; Terry NLJ; Sonavane S; Deshmane SP; Woodruff PG; Oelsner EC; Bodduluri S; Han MK; Labaki WW; Michael Wells J; Martinez FJ; Barr RG; Dransfield MT;
    Respir Res; 2018 Dec; 19(1):257. PubMed ID: 30563576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.